Results 181 to 190 of about 197,951 (371)

The microcirculation in atherogenesis [PDF]

open access: yesCardiovascular Research, 1996
H. A. Lehr, Konrad Messmer
openaire   +3 more sources

Refining laissez‐faire treatment of periocular tumour defects by exploring the impact of defect localization and geometry on the healing process

open access: yesActa Ophthalmologica, EarlyView.
Abstract Background Large lower eyelid defects resulting from tumour removal are frequently reconstructed using a tarsoconjunctival flap from the upper eyelid together with an overlying free skin graft, the so‐called Hughes procedure. One disadvantage of this technique is that the tarsoconjunctival flap occludes the eye during the revascularization of ...
Jens Nääv Ottosson   +7 more
wiley   +1 more source

A computational model for analysis of uncoupled NO synthase on nitric oxide and superoxide interaction in microcirculation [PDF]

open access: yes, 2007
Nitric oxide (NO) produced by endothelial cells is a key component for blood-vessel dilation. Dilation is achieved through smooth muscle relaxation as a response to NO transport.
Kavdia, Mahendra, Richardson, William
core   +2 more sources

STUDIES ON THE MICROCIRCULATION UNDER THE INFLUENCE OF THE AUTONOMIC NERVE IRRITATION

open access: bronze, 1962
Yoichi Yamaguchi   +7 more
openalex   +2 more sources

Targeting ROCK1/YAP1 Axis Ameliorates Inflammation‐Induced Prostatic Hyperplasia via Stabilising SIRT1‐Dependent Mitochondrial Dynamics

open access: yesCell Proliferation, EarlyView.
Prostate‐specific YAP1 overexpression induces pathological BPH phenogenesis. Targeting ROCK1/YAP1 with fasudil and verteporfin alleviates inflammatory BPH lesions. YAP1 orchestrates mitochondrial dysfunction and oxidative stress via suppressing SIRT1 function.
Dongxu Lin   +9 more
wiley   +1 more source

An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic rats

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Sodium‐glucose cotransporter 2 (SGLT2) inhibitors consistently demonstrate renal protection against progressive kidney disease. We hypothesised that SGLT2 inhibition reduces blood glucose levels in peri‐proximal tubular capillaries by limiting reabsorption from the tubular filtrate, thereby safeguarding the renal microvasculature from ...
Anqi Zhang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy